Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-beta-4-fragment

Ac-SDKP, Goralatide, Seraspenide

Quick Stats
Studies 83
Trials 3
Score 2
2007 pubmed 16 citations

Subcellular distribution of thymosin beta4.

Zoubek. Robert E RE; Hannappel. Ewald E

Key Findings

  • Thymosin beta‑4 and its fragments can enter the nucleus in living cells but are blocked when the nuclear pores are isolated.
  • Changing the basic lysine cluster or the actin‑binding region does not stop nuclear entry.
  • The movement into the nucleus appears to be passive diffusion rather than active transport.

Practical Outcomes

  • For biohackers, this means that taking thymosin beta‑4 is unlikely to target the nucleus specifically, and there’s no evidence here to change dosing or timing for any performance benefit. The findings are mainly mechanistic and don’t translate into a new protocol or clear health advantage.

Summary

The study shows that thymosin beta‑4 and its pieces can move into the cell nucleus by simple diffusion, not needing special transport proteins, and this happens the same way whether the peptide is normal or has certain parts changed.

Abstract

The localization of Oregon Green cadaverine-labeled thymosin beta(4), its fragments, and variants was investigated in cytoplasm-depleted A431 cells and in microinjected cells without and with fixation. The studied thymosin beta(4) variants included substitutions of the lysine residues within the basic cluster (14-KSKLKK-19) and the actin-binding motif (17-LKKTETQ-23). In contrast to Oregon Green cadaverine, none of the variants or fragments of thymosin beta(4) could pass the intact nuclear pore of cytoplasm-depleted cells and were hence excluded from the nucleus. However, an equal distribution of all thymosin beta(4) variants was observed in living cells. The nuclear localization is neither dependent on the actin-binding ability of thymosin beta(4) nor on its basic lysine cluster. The equal distribution of the beta-thymosins, the ability of the fragments thymosin beta(4)(1-26) and beta(4)(27-43) to enter the nucleus in intact cells immediately after injection, and their exclusion from cytoplasm-depleted nuclei make it unlikely that they are transported by a single transport protein. A passive but regulated diffusion could explain the described ability of thymosin beta(4) to shuttle into the nucleus.

Study Information

Provider

pubmed

Year

2007

Date

2007-06-13T00:00:00.000Z

DOI

10.1196/annals.1415.031

Citations

16

References

19